The Lancet, 0140-6736

Journal

1 - 10 out of 424Page size: 10

Publications

  1. 2020
  2. Accepted/In press

    Effectiveness of the Arabin cervical pessary to prevent preterm birth in women with a twin pregnancy and short cervix: open randomised trial and updated meta-analysis

    Mark Kilby, 21 Jan 2020, (Accepted/In press) In : The Lancet.

    Research output: Contribution to journal › Article

  3. Accepted/In press

    Quality of Primary Health Care in China: Challenges and Recommendations

    KK Cheng & 10 others, , 15 Jan 2020, (Accepted/In press) In : The Lancet.

    Research output: Contribution to journal › Article

  4. 2019
  5. Accepted/In press

    Multicentre randomised controlled trial of prophylactic biologic mesh reinforcement versus standard closure of stoma site

    Aneel Bhangu, 18 Oct 2019, (Accepted/In press) In : The Lancet.

    Research output: Contribution to journal › Article

  6. Published

    Extension of the CONSORT and SPIRIT statements

    5 Oct 2019, In : The Lancet. 394, 10205, p. 1225-1225 1 p.

    Research output: Contribution to journal › Letter

  7. Published

    AI can now identify atrial fibrillation through sinus rhythm

    Larissa Fabritz, 7 Sep 2019, In : The Lancet. 394, 10201, p. 812-813 2 p.

    Research output: Contribution to journal › Comment/debate

  8. Published

    Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial

    Karla Hemming & 5 others, , G Neil Thomas, Tom Marshall, KK Cheng, 24 Aug 2019, In : Lancet. 394, 10199, p. 672-683 12 p.

    Research output: Contribution to journal › Article

  9. Published

    The state of hypertension care in 44 low- and middle-income countries: a cross-sectional study of individual-level nationally representative data from 1.1 million adults

    & 23 others, , Justine Davies, 24 Aug 2019, In : The Lancet. 394, 10199, p. 652-662 11 p.

    Research output: Contribution to journal › Article

  10. Published

    UK consultation on pulse oximetry screening for critical congenital heart defects in newborns

    Andrew Ewer, 1 Jul 2019, In : The Lancet. 394, 10193, p. 103-104 2 p.

    Research output: Contribution to journal › Comment/debate

  11. Published

    6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

    29 Jun 2019, In : The Lancet. 393, 10191, p. 2599-2612 14 p.

    Research output: Contribution to journal › Article

  12. Published

    Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Daniel Rea, 6 Apr 2019, In : The Lancet. 393, 10179, p. 1440-1452

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 ...43 Next